Feedback / Questions
axitinib injectable suspension (CLS-AX) - Clearside Biomedical
https://www.globenewswire.com/news-release/2025/03/20/3046109/0/en/Clearside-Biomedical-s-Lead-Clinical-Program-CLS-AX-in-Wet-AMD-and-Suprachoroidal-Delivery-Platform-Highlighted-at-the-2025-Wet-AMD-Diabetic-Eye-Disease-Summit.html
Mar 20, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next